Oncolytic Virus Therapy Industry Research Report 2024
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
According to APO Research, The global Oncolytic Virus Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Amgen, Colytics Biotech, Iralytics and Ransgene SA are the leading providers of oncolytic virus therapy, with the first 3 accounting for about 60% of the market.
North America and Europe are the main markets, each accounting for about 40% of the market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Oncolytic Virus Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncolytic Virus Therapy.
The Oncolytic Virus Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oncolytic Virus Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncolytic Virus Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oncolytic Virus Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncolytic Virus Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Oncolytic Virus Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Chapter 13: The main points and conclusions of the report.
According to APO Research, The global Oncolytic Virus Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Amgen, Colytics Biotech, Iralytics and Ransgene SA are the leading providers of oncolytic virus therapy, with the first 3 accounting for about 60% of the market.
North America and Europe are the main markets, each accounting for about 40% of the market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Oncolytic Virus Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncolytic Virus Therapy.
The Oncolytic Virus Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oncolytic Virus Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Amgen
- Oncolytics Biotech
- Viralytics
- Transgene SA
- Oncolys BioPharma
- Targovax
- PsiOxus Therapeutics
- SillaJen Biotherapeutics
- Sorrento Therapeutics
- Lokon Pharma
- Genelux Corporation
- Vyriad
- TILT Biotherapeutics
- Cold Genesys
- HSV-based Oncolytic Viruses
- Adenoviruses-based Oncolytic Viruses
- Vaccinia Virus-based Oncolytic Viruses
- Vesicular Stomatitis Virus-based Oncolytic Viruses
- Newcastle Disease Virus-based Oncolytic Viruses
- Melanoma
- Prostate Cancer
- Breast Cancer
- Ovarian Cancer
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncolytic Virus Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oncolytic Virus Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncolytic Virus Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Oncolytic Virus Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Oncolytic Virus Therapy by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 HSV-based Oncolytic Viruses
2.2.3 Adenoviruses-based Oncolytic Viruses
2.2.4 Vaccinia Virus-based Oncolytic Viruses
2.2.5 Vesicular Stomatitis Virus-based Oncolytic Viruses
2.2.6 Newcastle Disease Virus-based Oncolytic Viruses
2.3 Oncolytic Virus Therapy by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Melanoma
2.3.3 Prostate Cancer
2.3.4 Breast Cancer
2.3.5 Ovarian Cancer
2.3.6 Others
2.4 Assumptions and Limitations
3 ONCOLYTIC VIRUS THERAPY BREAKDOWN DATA BY TYPE
3.1 Global Oncolytic Virus Therapy Historic Market Size by Type (2019-2024)
3.2 Global Oncolytic Virus Therapy Forecasted Market Size by Type (2025-2030)
4 ONCOLYTIC VIRUS THERAPY BREAKDOWN DATA BY APPLICATION
4.1 Global Oncolytic Virus Therapy Historic Market Size by Application (2019-2024)
4.2 Global Oncolytic Virus Therapy Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Oncolytic Virus Therapy Market Perspective (2019-2030)
5.2 Global Oncolytic Virus Therapy Growth Trends by Region
5.2.1 Global Oncolytic Virus Therapy Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Oncolytic Virus Therapy Historic Market Size by Region (2019-2024)
5.2.3 Oncolytic Virus Therapy Forecasted Market Size by Region (2025-2030)
5.3 Oncolytic Virus Therapy Market Dynamics
5.3.1 Oncolytic Virus Therapy Industry Trends
5.3.2 Oncolytic Virus Therapy Market Drivers
5.3.3 Oncolytic Virus Therapy Market Challenges
5.3.4 Oncolytic Virus Therapy Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Oncolytic Virus Therapy Players by Revenue
6.1.1 Global Top Oncolytic Virus Therapy Players by Revenue (2019-2024)
6.1.2 Global Oncolytic Virus Therapy Revenue Market Share by Players (2019-2024)
6.2 Global Oncolytic Virus Therapy Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Oncolytic Virus Therapy Head office and Area Served
6.4 Global Oncolytic Virus Therapy Players, Product Type & Application
6.5 Global Oncolytic Virus Therapy Players, Date of Enter into This Industry
6.6 Global Oncolytic Virus Therapy Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Oncolytic Virus Therapy Market Size (2019-2030)
7.2 North America Oncolytic Virus Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Oncolytic Virus Therapy Market Size by Country (2019-2024)
7.4 North America Oncolytic Virus Therapy Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Oncolytic Virus Therapy Market Size (2019-2030)
8.2 Europe Oncolytic Virus Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Oncolytic Virus Therapy Market Size by Country (2019-2024)
8.4 Europe Oncolytic Virus Therapy Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Oncolytic Virus Therapy Market Size (2019-2030)
9.2 Asia-Pacific Oncolytic Virus Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Oncolytic Virus Therapy Market Size by Country (2019-2024)
9.4 Asia-Pacific Oncolytic Virus Therapy Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Oncolytic Virus Therapy Market Size (2019-2030)
10.2 Latin America Oncolytic Virus Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Oncolytic Virus Therapy Market Size by Country (2019-2024)
10.4 Latin America Oncolytic Virus Therapy Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Oncolytic Virus Therapy Market Size (2019-2030)
11.2 Middle East & Africa Oncolytic Virus Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2019-2024)
11.4 Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 Amgen
12.1.1 Amgen Company Information
12.1.2 Amgen Business Overview
12.1.3 Amgen Revenue in Oncolytic Virus Therapy Business (2019-2024)
12.1.4 Amgen Oncolytic Virus Therapy Product Portfolio
12.1.5 Amgen Recent Developments
12.2 Oncolytics Biotech
12.2.1 Oncolytics Biotech Company Information
12.2.2 Oncolytics Biotech Business Overview
12.2.3 Oncolytics Biotech Revenue in Oncolytic Virus Therapy Business (2019-2024)
12.2.4 Oncolytics Biotech Oncolytic Virus Therapy Product Portfolio
12.2.5 Oncolytics Biotech Recent Developments
12.3 Viralytics
12.3.1 Viralytics Company Information
12.3.2 Viralytics Business Overview
12.3.3 Viralytics Revenue in Oncolytic Virus Therapy Business (2019-2024)
12.3.4 Viralytics Oncolytic Virus Therapy Product Portfolio
12.3.5 Viralytics Recent Developments
12.4 Transgene SA
12.4.1 Transgene SA Company Information
12.4.2 Transgene SA Business Overview
12.4.3 Transgene SA Revenue in Oncolytic Virus Therapy Business (2019-2024)
12.4.4 Transgene SA Oncolytic Virus Therapy Product Portfolio
12.4.5 Transgene SA Recent Developments
12.5 Oncolys BioPharma
12.5.1 Oncolys BioPharma Company Information
12.5.2 Oncolys BioPharma Business Overview
12.5.3 Oncolys BioPharma Revenue in Oncolytic Virus Therapy Business (2019-2024)
12.5.4 Oncolys BioPharma Oncolytic Virus Therapy Product Portfolio
12.5.5 Oncolys BioPharma Recent Developments
12.6 Targovax
12.6.1 Targovax Company Information
12.6.2 Targovax Business Overview
12.6.3 Targovax Revenue in Oncolytic Virus Therapy Business (2019-2024)
12.6.4 Targovax Oncolytic Virus Therapy Product Portfolio
12.6.5 Targovax Recent Developments
12.7 PsiOxus Therapeutics
12.7.1 PsiOxus Therapeutics Company Information
12.7.2 PsiOxus Therapeutics Business Overview
12.7.3 PsiOxus Therapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024)
12.7.4 PsiOxus Therapeutics Oncolytic Virus Therapy Product Portfolio
12.7.5 PsiOxus Therapeutics Recent Developments
12.8 SillaJen Biotherapeutics
12.8.1 SillaJen Biotherapeutics Company Information
12.8.2 SillaJen Biotherapeutics Business Overview
12.8.3 SillaJen Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024)
12.8.4 SillaJen Biotherapeutics Oncolytic Virus Therapy Product Portfolio
12.8.5 SillaJen Biotherapeutics Recent Developments
12.9 Sorrento Therapeutics
12.9.1 Sorrento Therapeutics Company Information
12.9.2 Sorrento Therapeutics Business Overview
12.9.3 Sorrento Therapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024)
12.9.4 Sorrento Therapeutics Oncolytic Virus Therapy Product Portfolio
12.9.5 Sorrento Therapeutics Recent Developments
12.10 Lokon Pharma
12.10.1 Lokon Pharma Company Information
12.10.2 Lokon Pharma Business Overview
12.10.3 Lokon Pharma Revenue in Oncolytic Virus Therapy Business (2019-2024)
12.10.4 Lokon Pharma Oncolytic Virus Therapy Product Portfolio
12.10.5 Lokon Pharma Recent Developments
12.11 Genelux Corporation
12.11.1 Genelux Corporation Company Information
12.11.2 Genelux Corporation Business Overview
12.11.3 Genelux Corporation Revenue in Oncolytic Virus Therapy Business (2019-2024)
12.11.4 Genelux Corporation Oncolytic Virus Therapy Product Portfolio
12.11.5 Genelux Corporation Recent Developments
12.12 Vyriad
12.12.1 Vyriad Company Information
12.12.2 Vyriad Business Overview
12.12.3 Vyriad Revenue in Oncolytic Virus Therapy Business (2019-2024)
12.12.4 Vyriad Oncolytic Virus Therapy Product Portfolio
12.12.5 Vyriad Recent Developments
12.13 TILT Biotherapeutics
12.13.1 TILT Biotherapeutics Company Information
12.13.2 TILT Biotherapeutics Business Overview
12.13.3 TILT Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024)
12.13.4 TILT Biotherapeutics Oncolytic Virus Therapy Product Portfolio
12.13.5 TILT Biotherapeutics Recent Developments
12.14 Cold Genesys
12.14.1 Cold Genesys Company Information
12.14.2 Cold Genesys Business Overview
12.14.3 Cold Genesys Revenue in Oncolytic Virus Therapy Business (2019-2024)
12.14.4 Cold Genesys Oncolytic Virus Therapy Product Portfolio
12.14.5 Cold Genesys Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Oncolytic Virus Therapy by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 HSV-based Oncolytic Viruses
2.2.3 Adenoviruses-based Oncolytic Viruses
2.2.4 Vaccinia Virus-based Oncolytic Viruses
2.2.5 Vesicular Stomatitis Virus-based Oncolytic Viruses
2.2.6 Newcastle Disease Virus-based Oncolytic Viruses
2.3 Oncolytic Virus Therapy by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Melanoma
2.3.3 Prostate Cancer
2.3.4 Breast Cancer
2.3.5 Ovarian Cancer
2.3.6 Others
2.4 Assumptions and Limitations
3 ONCOLYTIC VIRUS THERAPY BREAKDOWN DATA BY TYPE
3.1 Global Oncolytic Virus Therapy Historic Market Size by Type (2019-2024)
3.2 Global Oncolytic Virus Therapy Forecasted Market Size by Type (2025-2030)
4 ONCOLYTIC VIRUS THERAPY BREAKDOWN DATA BY APPLICATION
4.1 Global Oncolytic Virus Therapy Historic Market Size by Application (2019-2024)
4.2 Global Oncolytic Virus Therapy Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Oncolytic Virus Therapy Market Perspective (2019-2030)
5.2 Global Oncolytic Virus Therapy Growth Trends by Region
5.2.1 Global Oncolytic Virus Therapy Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Oncolytic Virus Therapy Historic Market Size by Region (2019-2024)
5.2.3 Oncolytic Virus Therapy Forecasted Market Size by Region (2025-2030)
5.3 Oncolytic Virus Therapy Market Dynamics
5.3.1 Oncolytic Virus Therapy Industry Trends
5.3.2 Oncolytic Virus Therapy Market Drivers
5.3.3 Oncolytic Virus Therapy Market Challenges
5.3.4 Oncolytic Virus Therapy Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Oncolytic Virus Therapy Players by Revenue
6.1.1 Global Top Oncolytic Virus Therapy Players by Revenue (2019-2024)
6.1.2 Global Oncolytic Virus Therapy Revenue Market Share by Players (2019-2024)
6.2 Global Oncolytic Virus Therapy Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Oncolytic Virus Therapy Head office and Area Served
6.4 Global Oncolytic Virus Therapy Players, Product Type & Application
6.5 Global Oncolytic Virus Therapy Players, Date of Enter into This Industry
6.6 Global Oncolytic Virus Therapy Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Oncolytic Virus Therapy Market Size (2019-2030)
7.2 North America Oncolytic Virus Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Oncolytic Virus Therapy Market Size by Country (2019-2024)
7.4 North America Oncolytic Virus Therapy Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Oncolytic Virus Therapy Market Size (2019-2030)
8.2 Europe Oncolytic Virus Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Oncolytic Virus Therapy Market Size by Country (2019-2024)
8.4 Europe Oncolytic Virus Therapy Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Oncolytic Virus Therapy Market Size (2019-2030)
9.2 Asia-Pacific Oncolytic Virus Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Oncolytic Virus Therapy Market Size by Country (2019-2024)
9.4 Asia-Pacific Oncolytic Virus Therapy Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Oncolytic Virus Therapy Market Size (2019-2030)
10.2 Latin America Oncolytic Virus Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Oncolytic Virus Therapy Market Size by Country (2019-2024)
10.4 Latin America Oncolytic Virus Therapy Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Oncolytic Virus Therapy Market Size (2019-2030)
11.2 Middle East & Africa Oncolytic Virus Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2019-2024)
11.4 Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 Amgen
12.1.1 Amgen Company Information
12.1.2 Amgen Business Overview
12.1.3 Amgen Revenue in Oncolytic Virus Therapy Business (2019-2024)
12.1.4 Amgen Oncolytic Virus Therapy Product Portfolio
12.1.5 Amgen Recent Developments
12.2 Oncolytics Biotech
12.2.1 Oncolytics Biotech Company Information
12.2.2 Oncolytics Biotech Business Overview
12.2.3 Oncolytics Biotech Revenue in Oncolytic Virus Therapy Business (2019-2024)
12.2.4 Oncolytics Biotech Oncolytic Virus Therapy Product Portfolio
12.2.5 Oncolytics Biotech Recent Developments
12.3 Viralytics
12.3.1 Viralytics Company Information
12.3.2 Viralytics Business Overview
12.3.3 Viralytics Revenue in Oncolytic Virus Therapy Business (2019-2024)
12.3.4 Viralytics Oncolytic Virus Therapy Product Portfolio
12.3.5 Viralytics Recent Developments
12.4 Transgene SA
12.4.1 Transgene SA Company Information
12.4.2 Transgene SA Business Overview
12.4.3 Transgene SA Revenue in Oncolytic Virus Therapy Business (2019-2024)
12.4.4 Transgene SA Oncolytic Virus Therapy Product Portfolio
12.4.5 Transgene SA Recent Developments
12.5 Oncolys BioPharma
12.5.1 Oncolys BioPharma Company Information
12.5.2 Oncolys BioPharma Business Overview
12.5.3 Oncolys BioPharma Revenue in Oncolytic Virus Therapy Business (2019-2024)
12.5.4 Oncolys BioPharma Oncolytic Virus Therapy Product Portfolio
12.5.5 Oncolys BioPharma Recent Developments
12.6 Targovax
12.6.1 Targovax Company Information
12.6.2 Targovax Business Overview
12.6.3 Targovax Revenue in Oncolytic Virus Therapy Business (2019-2024)
12.6.4 Targovax Oncolytic Virus Therapy Product Portfolio
12.6.5 Targovax Recent Developments
12.7 PsiOxus Therapeutics
12.7.1 PsiOxus Therapeutics Company Information
12.7.2 PsiOxus Therapeutics Business Overview
12.7.3 PsiOxus Therapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024)
12.7.4 PsiOxus Therapeutics Oncolytic Virus Therapy Product Portfolio
12.7.5 PsiOxus Therapeutics Recent Developments
12.8 SillaJen Biotherapeutics
12.8.1 SillaJen Biotherapeutics Company Information
12.8.2 SillaJen Biotherapeutics Business Overview
12.8.3 SillaJen Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024)
12.8.4 SillaJen Biotherapeutics Oncolytic Virus Therapy Product Portfolio
12.8.5 SillaJen Biotherapeutics Recent Developments
12.9 Sorrento Therapeutics
12.9.1 Sorrento Therapeutics Company Information
12.9.2 Sorrento Therapeutics Business Overview
12.9.3 Sorrento Therapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024)
12.9.4 Sorrento Therapeutics Oncolytic Virus Therapy Product Portfolio
12.9.5 Sorrento Therapeutics Recent Developments
12.10 Lokon Pharma
12.10.1 Lokon Pharma Company Information
12.10.2 Lokon Pharma Business Overview
12.10.3 Lokon Pharma Revenue in Oncolytic Virus Therapy Business (2019-2024)
12.10.4 Lokon Pharma Oncolytic Virus Therapy Product Portfolio
12.10.5 Lokon Pharma Recent Developments
12.11 Genelux Corporation
12.11.1 Genelux Corporation Company Information
12.11.2 Genelux Corporation Business Overview
12.11.3 Genelux Corporation Revenue in Oncolytic Virus Therapy Business (2019-2024)
12.11.4 Genelux Corporation Oncolytic Virus Therapy Product Portfolio
12.11.5 Genelux Corporation Recent Developments
12.12 Vyriad
12.12.1 Vyriad Company Information
12.12.2 Vyriad Business Overview
12.12.3 Vyriad Revenue in Oncolytic Virus Therapy Business (2019-2024)
12.12.4 Vyriad Oncolytic Virus Therapy Product Portfolio
12.12.5 Vyriad Recent Developments
12.13 TILT Biotherapeutics
12.13.1 TILT Biotherapeutics Company Information
12.13.2 TILT Biotherapeutics Business Overview
12.13.3 TILT Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024)
12.13.4 TILT Biotherapeutics Oncolytic Virus Therapy Product Portfolio
12.13.5 TILT Biotherapeutics Recent Developments
12.14 Cold Genesys
12.14.1 Cold Genesys Company Information
12.14.2 Cold Genesys Business Overview
12.14.3 Cold Genesys Revenue in Oncolytic Virus Therapy Business (2019-2024)
12.14.4 Cold Genesys Oncolytic Virus Therapy Product Portfolio
12.14.5 Cold Genesys Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
